| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |